Calling amplified haplotypes in next generation tumor sequence data

Genome Research

Volumn 22, Issue 2, 2012, Pages 362-374

  Dewal, Ninad ^a   Hu, Yang ^b   Freedman, Matthew L ^c,d   LaFramboise, Thomas ^e   Pe'Er, Itsik ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Dana Farber Cancer Institute ^*  (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AMPLICON; ARTICLE; CANCER GENETICS; COPY NUMBER VARIATION; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC VARIABILITY; HAPLOTYPE; HETEROZYGOSITY; PRIORITY JOURNAL; STATISTICAL MODEL;

COMPUTATIONAL BIOLOGY; COMPUTER SIMULATION; GENE AMPLIFICATION; HAPLOTYPES; HUMANS; MODELS, GENETIC; NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84863011867     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.122564.111     Document Type: Article

References (92)

1. The 1000 Genomes Project Consortium. 2010. A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073.
2. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, et al. 2009. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 41: 585-590.
3. Alkan C, Kidd JM, Marques-Bonet T, Aksay G, Antonacci F, Hormozdiari F, Kitzman JO, Baker C, Malig M, Mutlu O, et al. 2009. Personalized copy number and segmental duplication maps using next-generation sequencing. Nat Genet 41: 1061-1067.
4. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, et al. 2008. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622. (Pubitemid 351601203)
5. Amundadottir LT, Sulem P, Gudmundsson J, Helgason A, Baker A, Agnarsson BA, Sigurdsson A, Benediktsdottir KR, Cazier JB, Sainz J, et al. 2006. A common variant associated with prostate cancer in European and African populations. Nat Genet 38: 652-658. (Pubitemid 43927306)
6. Anders S, Huber W. 2010. Differential expression analysis for sequence count data. Genome Biol 11: R106. doi: 10.1186/gb-2010-11-10-r106.
7. Barbera MA, Petes TD. 2006. Selection and analysis of spontaneous reciprocal mitotic cross-overs in Saccharomyces cerevisiae. Proc Natl Acad Sci 103: 12819-12824. (Pubitemid 44298645)
8. Bentley DR, Balasubramanian S, Swerdlow HP, Smith GP, Milton J, Brown CG, Hall KP, Evers DJ, Barnes CL, Bignell HR, et al. 2008. Accurate whole human genome sequencing using reversible terminator chemistry. Nature 456: 53-59.
9. Bentz M, Plesch A, Stilgenbauer S, Dohner H, Lichter P. 1998. Minimal sizes of deletions detected by comparative genomic hybridization. Genes Chromosomes Cancer 21: 172-175. (Pubitemid 28081245)
10. Browning SR, Browning BL. 2007. Rapid and accurate haplotype phasing andmissing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 81: 1084-1097. (Pubitemid 47580259)
11. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, Murphree AL, Strong LC, White RL. 1983. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305: 779-784. (Pubitemid 13010953)
12. Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, Pohl CS, McGrath SD, Wendl MC, Zhang Q, Locke DP, et al. 2009. BreakDancer: An algorithm for high-resolution mapping of genomic structural variation. Nat Methods 6: 677-681.
13. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH. 1996. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56: 3091-3102. (Pubitemid 26199756)
14. Chiang DY, Getz G, Jaffe DB, O'Kelly MJ, Zhao X, Carter SL, Russ C, Nusbaum C, Meyerson M, Lander ES. 2009. High-resolution mapping of copy-number alterations with massively parallel sequencing. Nat Methods 6: 99-103.
15. Chung CC, Magalhaes WC, Gonzalez-Bosquet J, Chanock SJ. 2010. Genome-wide association studies in cancer - Current and future directions. Carcinogenesis 31: 111-120.
16. Dalca AV, Brudno M. 2010. Genome variation discovery with high-throughput sequencing data. Brief Bioinform 11: 3-14.
17. de Koning JP, Wakabayashi Y, Nagase H, Mao JH, Balmain A. 2007. Convergence of congenic mapping and allele-specific alterations in tumors for the resolution of the Skts1 skin tumor susceptibility locus. Oncogene 26: 4171-4178. (Pubitemid 46920176)
18. Dewal N, Freedman ML, LaFramboise T, Pe'er I. 2010. Power to detect selective allelic amplification in genome-wide scans of tumor data. Bioinformatics 26: 518-528.
19. Easton DF, Eeles RA. 2008. Genome-wide association studies in cancer. Hum Mol Genet 17: R109-R115.
20. Eronen L, Geerts F, Toivonen H. 2006. HaploRec: Efficient and accurate large-scale reconstruction of haplotypes. BMC Bioinformatics 7: 542. doi: 10.1186/1471-2105-7-542.
21. Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, et al. 2003. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat Genet 34: 403-412. (Pubitemid 36935333)
22. Fletcher O, Johnson N, Gibson L, Coupland B, Fraser A, Leonard A, dos Santos Silva I, Ashworth A, Houlston R, Peto J. 2008. Association of genetic variants at 8q24 with breast cancer risk. Cancer Epidemiol Biomarkers Prev 17: 702-705. (Pubitemid 351469223)
23. Freedman ML, Haiman CA, Patterson N, McDonald GJ, Tandon A, Waliszewska A, Penney K, Steen RG, Ardlie K, John EM, et al. 2006. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci 103: 14068-14073. (Pubitemid 44452981)
24. Gharizadeh B, Nordstrom T, Ahmadian A, Ronaghi M, Nyren P. 2002. Long-read pyrosequencing using pure 2′-deoxyadenosine-5′-O′- (1-thiotriphosphate) Sp-isomer. Anal Biochem 301: 82-90. (Pubitemid 34113681)
25. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. 1990. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 250: 1684-1689. (Pubitemid 120031871)
26. Hartl DL, Clark AG. 2007. Principles of population genetics. Sinauer Associates, Sunderland, MA.
27. Heap GA, Yang JH, Downes K, Healy BC, Hunt KA, Bockett N, Franke L, Dubois PC, Mein CA, Dobson RJ, et al. 2010. Genome-wide analysis of allelic expression imbalance in human primary cells by high-throughput transcriptome resequencing. Hum Mol Genet 19: 122-134.
28. Hienonen T, Salovaara R, Mecklin JP, Jarvinen H, Karhu A, Aaltonen LA. 2006. Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers. Int J Cancer 118: 505-508. (Pubitemid 41779093)
29. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA. 2009. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci 106: 9362-9367.
30. Hormozdiari F, Alkan C, Eichler EE, Sahinalp SC. 2009. Combinatorial algorithms for structural variation detection in high-throughput sequenced genomes. Genome Res 19: 1270-1278.
31. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, et al. 2008. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637. (Pubitemid 351483367)
32. The International HapMap Consortium. 2005. A haplotype map of the human genome. Nature 437: 1299-1320.
33. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, et al. 2004. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299-303. (Pubitemid 38282757)
34. Jones AV, Chase A, Silver RT, Oscier D, Zoi K, Wang YL, Cario H, Pahl HL, Collins A, Reiter A, et al. 2009. JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms. Nat Genet 41: 446-449.
35. Joos S, Bergerheim US, Pan Y,Matsuyama H, BentzM, duManoir S, Lichter P. 1995. Mapping of chromosomal gains and losses in prostate cancer by comparative genomic hybridization. Genes Chromosomes Cancer 14: 267-276.
36. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. 1992. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821.
37. Kilpivaara O, Mukherjee S, Schram AM, Wadleigh M, Mullally A, Ebert BL, Bass A, Marubayashi S, Heguy A, Garcia-Manero G, et al. 2009. A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms. Nat Genet 41: 455-459.
38. Kimmel G, Shamir R. 2005. A block-free hidden Markov model for genotypes and its application to disease association. J Comput Biol 12: 1243-1260. (Pubitemid 44743641)
39. Komura D, Shen F, Ishikawa S, Fitch KR, Chen W, Zhang J, Liu G, Ihara S, Nakamura H, HurlesME, et al. 2006. Genome-wide detection of human copy number variations using high-density DNA oligonucleotide arrays. Genome Res 16: 1575-1584. (Pubitemid 44878496)
40. Korbel JO, Urban AE, Affourtit JP, Godwin B, Grubert F, Simons JF, Kim PM, Palejev D, Carriero NJ, Du L, et al. 2007. Paired-end mapping reveals extensive structural variation in the human genome. Science 318: 420-426. (Pubitemid 47614521)
41. Korn WM, Yasutake T, Kuo WL, Warren RS, Collins C, Tomita M, Gray J, Waldman FM. 1999. Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Genes Chromosomes Cancer 25: 82-90. (Pubitemid 29226589)
42. Korn JM, Kuruvilla FG, McCarroll SA, Wysoker A, Nemesh J, Cawley S, Hubbell E, Veitch J, Collins PJ, Darvishi K, et al. 2008. Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs. Nat Genet 40: 1253-1260.
43. LaFave MC, Sekelsky J. 2009. Mitotic recombination: Why? when? how? where? PLoS Genet 5: e1000411. doi: 10.1371/journal.pgen.1000411.
44. LaFramboise T, Weir BA, Zhao X, Beroukhim R, Li C, Harrington D, Sellers WR, Meyerson M. 2005. Allele-specific amplification in cancer revealed by SNP array analysis. PLoS Comput Biol 1: e65. doi: 10.1371/journal.pcbi.0010065.
45. Laframboise T, Harrington D, Weir BA. 2007. PLASQ: A generalized linear model-based procedure to determine allelic dosage in cancer cells from SNP array data. Biostatistics 8: 323-336. (Pubitemid 46569593)
46. LaFramboise T, Dewal N, Wilkins K, Pe'er I, Freedman ML. 2010. Allelic selection of amplicons in glioblastoma revealed by combining somatic and germline analysis. PLoS Genet 6: e1001086. doi: 10.1371/journal.pgen.1001086.
47. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 10: R25. doi: 10.1186/gb-2009-10-3-r25.
48. Le Marchand L. 2009. Genome-wide association studies and colorectal cancer. Surg Oncol Clin N Am 18: 663-668.
49. Lee S, Hormozdiari F, Alkan C, Brudno M. 2009. MoDIL: Detecting small indels from clone-end sequencing with mixtures of distributions. Nat Methods 6: 473-474.
50. Li H, Durbin R. 2009. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
51. Li H, Ruan J, Durbin R. 2008a. Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res 18: 1851-1858.
52. Li R, Li Y, Kristiansen K, Wang J. 2008b. SOAP: Short oligonucleotide alignment program. Bioinformatics 24: 713-714. (Pubitemid 351321217)
53. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. 2009. The sequence alignment/map format and SAMtools. Bioinformatics 25: 2078-2079.
54. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. 2004. dChipSNP: Significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20: 1233-1240. (Pubitemid 38807579)
55. Marchini J, Cutler D, Patterson N, Stephens M, Eskin E, Halperin E, Lin S, Qin ZS, Munro HM, Abecasis GR, et al. 2006. A comparison of phasing algorithms for trios and unrelated individuals. Am J Hum Genet 78: 437-450. (Pubitemid 43291226)
56. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, Hirschhorn JN. 2008. Genome-wide association studies for complex traits: Consensus, uncertainty, and challenges. Nat Rev Genet 9: 356-369. (Pubitemid 351556063)
57. McKernan KJ, Peckham HE, Costa GL, McLaughlin SF, Fu Y, Tsung EF, Clouser CR, Duncan C, Ichikawa JK, Lee CC, et al. 2009. Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res 19: 1527-1541.
58. Medvedev P, Fiume M, Dzamba M, Smith T, Brudno M. 2010. Detecting copy number variation with mated short reads. Genome Res 20: 1613-1622.
59. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71. (Pubitemid 24345325)
60. Nagase H, Mao JH, Balmain A. 2003. Allele-specific Hras mutations and genetic alterations at tumor susceptibility loci in skin carcinomas from interspecific hybrid mice. Cancer Res 63: 4849-4853. (Pubitemid 37022616)
61. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, Kurokawa M, Chiba S, Bailey DK, Kennedy GC, et al. 2005. A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65: 6071-6079. (Pubitemid 40994391)
62. Network TCGA. 2008. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
63. Network TR. 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474: 609-615.
64. Nowell PC. 1976. The clonal evolution of tumor cell populations. Science 194: 23-28.
65. Olcaydu D, Harutyunyan A, Jager R, Berg T, Gisslinger B, Pabinger I, Gisslinger H, Kralovics R. 2009. A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. Nat Genet 41: 450-454.
66. Paques F, Haber JE. 1999. Multiple pathways of recombination induced by double-strand breaks in Saccharomyces cerevisiae. Microbiol Mol Biol Rev 63: 349-404. (Pubitemid 29264976)
67. Paris PL, Andaya A, Fridlyand J, Jain AN,Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, et al. 2004. Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet 13: 1303-1313. (Pubitemid 38961638)
68. Rastas P, Koivisto M, Mannila H, Ukkonen E. 2005. A hidden Markov technique for haplotype reconstruction. Lect Notes Comput Sci 3692: 140-151.
69. Robinson MD, Smyth GK. 2008. Small-sample estimation of negative binomial dispersion, with applications to SAGE data. Biostatistics 9: 321-332. (Pubitemid 351438556)
70. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139-140.
71. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P. 1996. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242: 84-89. (Pubitemid 26378519)
72. Scheet P, Stephens M. 2006. A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78: 629-644.
73. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Dohner H, Cremer T, Lichter P. 1997. Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances. Genes Chromosomes Cancer 20: 399-407. (Pubitemid 27520090)
74. Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, et al. 2009. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Hum Mol Genet 18: 2297-2304.
75. Stadler ZK, Gallagher DJ, Thom P, Offit K. 2010a. Genome-wide association studies of cancer: Principles and potential utility. Oncology (Williston Park) 24: 629-637.
76. Stadler ZK, Thom P, Robson ME, Weitzel JN, Kauff ND, Hurley KE, Devlin V, Gold B, Klein RJ, Offit K. 2010b. Genome-wide association studies of cancer. J Clin Oncol 28: 4255-4267.
77. Stephens M, Smith NJ, Donnelly P. 2001. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989. (Pubitemid 32289743)
78. Sun J, Liu W, Adams TS, Li X, Turner AR, Chang B, Kim JW, Zheng SL, Isaacs WB, Xu J. 2007a. DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies. Prostate 67: 692-700. (Pubitemid 46709438)
79. Sun S, Greenwood CM, Neal RM. 2007b. Haplotype inference using a Bayesian hidden Markov model. Genet Epidemiol 31: 937-948.
80. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, et al. 2008. A variant associated with nicotine dependence, lung cancer, and peripheral arterial disease. Nature 452: 638-642. (Pubitemid 351483366)
81. Tuch BB, Laborde RR, Xu X, Gu J, Chung CB, Monighetti CK, Stanley SJ, Olsen KD, Kasperbauer JL, Moore EJ, et al. 2010. Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS ONE 5: e9317. doi: 10.1371/journal.pone.0009317.
82. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, et al. 2010. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 42: 504-507.
83. Tuzun E, Sharp AJ, Bailey JA, Kaul R, Morrison VA, Pertz LM, Haugen E, Hayden H, Albertson D, Pinkel D, et al. 2005. Fine-scale structural variation of the human genome. Nat Genet 37: 727-732. (Pubitemid 41754889)
84. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J, et al. 1998. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280: 1077-1082. (Pubitemid 28234949)
85. Witte JS. 2010. Genome-wide association studies and beyond. Annu Rev Public Health 31: 9-20.
86. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G. 1995. Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792. (Pubitemid 26004412)
87. Wu X, Hildebrandt MA, Chang DW. 2009. Genome-wide association studies of bladder cancer risk: A field synopsis of progress and potential applications. Cancer Metastasis Rev 28: 269-280.
88. Xie C, Tammi MT. 2009. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics 10: 80. doi: 10.1186/1471-2105-10-80.
89. Yoon S, Xuan Z, Makarov V, Ye K, Sebat J. 2009. Sensitive and accurate detection of copy number variants using read depth of coverage. Genome Res 19: 1586-1592.
90. Zanke BW, Greenwood CM, Rangrej J, Kustra R, Tenesa A, Farrington SM, Prendergast J, Olschwang S, Chiang T, Crowdy E, et al. 2007. Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39: 989-994. (Pubitemid 47185183)
91. Zhang K, Li JB, Gao Y, Egli D, Xie B, Deng J, Li Z, Lee JH, Aach J, Leproust EM, et al. 2009. Digital RNA allelotyping reveals tissue-specific and allele-specific gene expression in human. Nat Methods 6: 613-618.
92. Zhao X, Weir BA, LaFramboise T, Lin M, Beroukhim R, Garraway L, Beheshti J, Lee JC, Naoki K, Richards WG, et al. 2005. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65: 5561-5570. (Pubitemid 40911156)